Cargando…
Pentraxin 3 as a Novel Marker in Cardiovascular Diseases?
Pentraxin 3 (also known as TNFAIP5, TSG-14) belongs to the superfamily of proteins characterized by cyclic multimeric structure. Pentraxin 3 (PTX3) is synthesized locally at the inflammatory sites by endothelial and smooth muscle cells upon exposure to inflammatory signals such as IL-1β, TNF-α or ox...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975313/ https://www.ncbi.nlm.nih.gov/pubmed/27683398 |
_version_ | 1782446703222194176 |
---|---|
author | Malinowski, Bartosz Grzesk, Grzegorz Grzesk, Elzbieta |
author_facet | Malinowski, Bartosz Grzesk, Grzegorz Grzesk, Elzbieta |
author_sort | Malinowski, Bartosz |
collection | PubMed |
description | Pentraxin 3 (also known as TNFAIP5, TSG-14) belongs to the superfamily of proteins characterized by cyclic multimeric structure. Pentraxin 3 (PTX3) is synthesized locally at the inflammatory sites by endothelial and smooth muscle cells upon exposure to inflammatory signals such as IL-1β, TNF-α or ox-LDL, but not IL-6. Furthermore, PTX3 is highly expressed in vascular cells and myocardial cells in patients with cardiomyopathy. These data suggest that pentraxin 3 may be a useful biomarker for local vascular inflammation and cardiovascular system disorders. |
format | Online Article Text |
id | pubmed-4975313 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | The Communications and Publications Division (CPD) of the IFCC |
record_format | MEDLINE/PubMed |
spelling | pubmed-49753132016-09-28 Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? Malinowski, Bartosz Grzesk, Grzegorz Grzesk, Elzbieta EJIFCC Research Article Pentraxin 3 (also known as TNFAIP5, TSG-14) belongs to the superfamily of proteins characterized by cyclic multimeric structure. Pentraxin 3 (PTX3) is synthesized locally at the inflammatory sites by endothelial and smooth muscle cells upon exposure to inflammatory signals such as IL-1β, TNF-α or ox-LDL, but not IL-6. Furthermore, PTX3 is highly expressed in vascular cells and myocardial cells in patients with cardiomyopathy. These data suggest that pentraxin 3 may be a useful biomarker for local vascular inflammation and cardiovascular system disorders. The Communications and Publications Division (CPD) of the IFCC 2011-12-22 /pmc/articles/PMC4975313/ /pubmed/27683398 Text en Copyright © International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Malinowski, Bartosz Grzesk, Grzegorz Grzesk, Elzbieta Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title_full | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title_fullStr | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title_full_unstemmed | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title_short | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
title_sort | pentraxin 3 as a novel marker in cardiovascular diseases? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975313/ https://www.ncbi.nlm.nih.gov/pubmed/27683398 |
work_keys_str_mv | AT malinowskibartosz pentraxin3asanovelmarkerincardiovasculardiseases AT grzeskgrzegorz pentraxin3asanovelmarkerincardiovasculardiseases AT grzeskelzbieta pentraxin3asanovelmarkerincardiovasculardiseases |